Clinical Trials Logo

Healthy Volunteers clinical trials

View clinical trials related to Healthy Volunteers.

Filter by:

NCT ID: NCT03542435 Completed - Healthy Volunteers Clinical Trials

Randomized, Double-Blind, Placebo-Controlled, MAD Study to Assess the Safety, Tolerability, and Pharmacokinetics of SXC 2023

Start date: April 26, 2018
Phase: Phase 1
Study type: Interventional

This is a randomized, double-blind, placebo-controlled, multiple ascending dose study conducted at one study center in the United States. Safety and tolerability will be assessed throughout the study and serial blood samples and urine samples will be collected for the safety and pharmacokinetic assessment of SXC-2023.

NCT ID: NCT03537508 Completed - Clinical trials for Healthy Volunteers (Meningococcal Infection)

Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US

Start date: April 25, 2018
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the immunogenicity and describe the safety of MenACYW conjugate vaccine and MENVEO® when both are administered concomitantly with routine pediatric vaccines to healthy infants and toddlers in the US.

NCT ID: NCT03533387 Completed - Healthy Volunteers Clinical Trials

Study of MN-166 (Ibudilast) Extended Release Tablet Formulations Compared With Capsules in Healthy Volunteers

Start date: April 11, 2018
Phase: Phase 1
Study type: Interventional

To compare the bioavailability and pharmacokinetic profiles of two different formulations MN-166 50mg, extended release (ER) tablets with MN-166 10mg capsules in a single-dose regimen in healthy volunteers

NCT ID: NCT03530514 Completed - Healthy Volunteers Clinical Trials

A Study to Examine the Safety, Tolerability and Biological Effects of REGN4461 in Healthy Volunteers

Start date: April 24, 2018
Phase: Phase 1
Study type: Interventional

The primary objective of the study is to evaluate the safety and tolerability of REGN4461 in healthy participants. The secondary objectives of the study are to: - Characterize the Pharmacokinetic (PK) profile of single and repeated doses of REGN4461 and evaluate the effects of baseline covariates on PK profile - Estimate the effects of repeated doses of REGN4461 on body weight over 12 weeks in overweight and obese participants - Assess the effects of repeated doses of REGN4461 on ad lib energy intake in overweight and obese participants - Evaluate the effects of single and repeated doses of REGN4461 on soluble forms of lipid-regulating proteins levels over time - Assess the immunogenicity of single and repeated doses of REGN4461

NCT ID: NCT03526744 Completed - Healthy Volunteers Clinical Trials

Marine Protein Hydrolysate as Dietary Supplement in Elderly Part II

MPH-DR
Start date: April 27, 2018
Phase: N/A
Study type: Interventional

The aim of this study is to investigate the potential effect of different doses of MPH supplement on glucose metabolism, hunger and appetite hormones.

NCT ID: NCT03525119 Completed - Healthy Volunteers Clinical Trials

Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) Co-administered With an Hepatitis A Virus Vaccine

Start date: May 16, 2018
Phase: Phase 3
Study type: Interventional

The purpose of this study is to investigate the immunogenicity and safety of the concomitant administration of TDV (subcutaneous [SC] injection) and of hepatitis A virus (HAV) vaccine (intramuscular [IM] injection) in healthy participants aged 18 to 60 years living in country(ies) non-endemic for both dengue and hepatitis.

NCT ID: NCT03522506 Completed - Healthy Volunteers Clinical Trials

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of TAK-925 Study in Sleep-Deprived Healthy Adults

Start date: May 9, 2018
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine the effect of TAK-925 after a single intravenous dose (compared to placebo) on promoting wakefulness as measured by sleep latency on the maintenance of wakefulness (MWT) in sleep-deprived healthy participants.

NCT ID: NCT03515421 Completed - Healthy Volunteers Clinical Trials

Project Frazier 3 Regulatory Clinical Evaluation

Start date: April 9, 2018
Phase: N/A
Study type: Interventional

Clinical Evaluation of Blood Glucose Monitoring Systems (BGMSs)

NCT ID: NCT03513432 Completed - Healthy Volunteers Clinical Trials

Influence of Beer on Gut Microbiota and Biochemical Outcomes: Alcohol Impact.

Start date: March 26, 2018
Phase: N/A
Study type: Interventional

Our aim is to assess the effects of moderate consumption of beer and non-alcoholic beer on gut microbiota and biochemical biomarkers in healthy adults.

NCT ID: NCT03510572 Completed - Parkinson Disease Clinical Trials

Evaluation of [18F]PI-2620 as a Potential Positron Emission Computed Tomography Radioligand for Imaging Tau Protein in the Brain

Start date: June 4, 2018
Phase: Early Phase 1
Study type: Interventional

The overall goal of this imaging trial is to evaluate [18F]PI-2620, a tau targeted positron emission computed tomography radioligand, in individuals with tauopathies and healthy volunteers (HV).